Lamivudine Tablet, Film Coated
Product Images NDC 65862-026

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 65862-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Virologic Response Through Week 48, Epv20001a,b (intent-to-treat) (Lamivudine Fig1)

A line graph depicting virologic response through 48 weeks for Lamivudine at two dosing regimens: 150 mg twice daily and 300 mg once daily. The y-axis shows the proportion of subjects with HIV-1 RNA below 400 copies per mL, and the x-axis represents treatment time in weeks, ranging from 0 to 48. Both dosing regimens show increasing response up to around week 20, then a slight decline through week 48.*

FDA Label Image

Package Label-principal Display Panel (150 mg (60 Tablets Bottle))

Lamivudine Tablets USP 150 mg film-coated tablet label from Aurobindo Pharma Limited. The label states each tablet contains 150 mg of lamivudine. Package contains 60 tablets. Distributed by Aurobindo Pharma USA, Inc., located in East Windsor, NJ. Storage instructions and a barcode are also shown.*

FDA Label Image

Package Label-principal Display Panel (150 mg Blister Carton 6 x 10 Unit-dose)

Packaging label for Lamivudine Tablets USP 150 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates a package of 60 tablets (6 x 10 unit-dose) with instructions to see the insert for dosage and administration. The label includes storage instructions and the distributor's address in East Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (300 mg (30 Tablets Bottle))

Lamivudine Tablets USP 300 mg film-coated tablets packaging label showing 30 tablets. The label includes the NDC 65862-026-30, distributor Aurobindo Pharma USA, Inc., storage instructions at 20° to 25°C, and a barcode on the right. The product is marked Rx only and made in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel (300 mg Blister Carton 3 x 10 Unit-dose)

Packaging label for Lamivudine Tablets USP 300 mg film-coated tablets by Aurobindo Pharma Limited. The label states 30 tablets (3 x 10 unit-dose) per package and includes storage instructions and distributor information. The design features blue and green accents with product and dosage information prominently displayed.*

FDA Label Image

Chemical Structure (Lamivudine Str)

Chemical structure of Lamivudine, showing the molecular arrangement including the pyrimidine base, sugar moiety with sulfur atom, and hydroxyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.